KPV guide & protocols

Almost every peptide on this site has to be injected, because a peptide swallowed is a peptide digested. KPV is the interesting exception, and the reason is worth understanding before you read a single dosing figure: the gut has a transporter that actively carries it in, and that transporter becomes more abundant in inflamed intestinal tissue. So the compound is picked up most where the problem is. That's an unusually elegant piece of biology and it's the whole reason the oral route on this page isn't wishful thinking.

Vial size isn't part of what follows, since the amount of bacteriostatic water you add sets your concentration either way. Our reconstitution calculator handles that math for whatever vial and target amount you're working with.

What it is

KPV is three amino acids long, which makes it about the smallest thing on this site. It's the tail end of alpha-MSH, a hormone the body already uses to damp down inflammation, and it turns out to carry a large share of that hormone's anti-inflammatory activity on its own.

Cutting it down did two useful things. It left behind the part of alpha-MSH that darkens skin and hair, which is why KPV doesn't tan you the way melanotan does. And it produced something small and stable enough to behave differently in the body than a full-size peptide would.

The mechanism that matters most is that KPV doesn't need the classic melanocortin receptors to work. It gets carried directly into gut lining cells by a transporter called PepT1, and once inside it quiets two of the main inflammatory signalling pathways. That receptor-independent route is the finding that separates KPV from its parent hormone.

What people use it for

The gut, first and by a distance. That covers everything from a diagnosed inflammatory bowel condition through to the vaguer midlife situation where digestion has become an unreliable narrator and nothing on a test comes back abnormal. The animal work is specifically about inflamed intestine, which makes this one of the better-matched compound-to-complaint pairings on the site.

Skin is the second thread, and it follows from the same anti-inflammatory action rather than from anything about collagen. People reach for it for irritated, reactive, or inflamed skin rather than for lines, which is the distinction between KPV and GHK-Cu.

Third is general inflammation, and that's the vaguest use and the one supported mostly by extrapolation. The animal work outside the gut exists but is thinner.

Formulations

KPV ships as a lyophilized powder. Across the vendors we track, 10 mg vials dominate by a wide margin, with 5 mg available from a handful and a long tail of larger sizes.

It's also one of the four compounds in the KLOW blend, alongside GHK-Cu, BPC-157 and TB-500, which is how a lot of people first encounter it. If you're running KLOW you're already taking KPV, at whatever share of the blend the vendor decided on.

Capsules exist from some suppliers, and unlike most oral peptide products the rationale here is real rather than marketing. That said, a capsule still has to survive the stomach to reach the intestine where the transporter is, and what proportion does isn't something anyone has measured in a person.

Dosing protocols

Nothing here comes from an approved product or a human study, because neither exists for this compound. The routes are separated because the reasoning behind them differs.

See the KPV research notes for the research behind these figures.

Injected patterns above are subcutaneous.

Why the oral route is worth taking seriously here

On most of this site, "oral peptide" is a warning sign. A peptide is a small protein, the stomach exists to take proteins apart, and a capsule of something meant for injection is usually an expensive way to eat amino acids.

KPV is different for two specific reasons. It's three amino acids long, and short chains survive digestion far better than long ones. And the gut actively transports it inward rather than leaving it to diffuse, using a carrier that becomes more abundant in inflamed tissue. That combination is why the animal work found oral dosing worked on colitis, and it's a genuine mechanism rather than an argument someone made up to sell capsules.

What it doesn't mean is that oral works as well as injection for anything outside the gut. The transporter is a gut transporter. If you're using KPV for skin or general inflammation, the argument for swallowing it largely evaporates.

Amount total, for planning your vial purchase. At 500 mcg daily an eight-week stretch runs 28 mg, so roughly three 10 mg vials. At 250 mcg daily the same stretch is 14 mg.

How much to reconstitute at once. A reconstituted vial keeps about 28 days refrigerated, and at 500 mcg daily that window uses 14 mg, so a 10 mg vial is comfortably inside it. At 250 mcg daily the window only reaches 7 mg and a full 10 mg vial leaves about 3 mg to expire, so the 5 mg vials a few vendors carry are the better buy at the lower amount. Working example: 10 mg into 2 mL of bacteriostatic water gives 5,000 mcg per mL, so 500 mcg is 500 divided by 5,000, times 100, which is 10 units on a standard U-100 insulin syringe, and 250 mcg is 5 units. See how much to reconstitute at once for the general math.

Cycling guidelines

Four to eight weeks on, then a break, is the pattern described most often, and nothing published establishes it. Longer continuous runs come up where the target is a chronic gut condition rather than a flare, which is a reasonable distinction to draw even though nobody has tested either shape.

There's no tolerance mechanism proposed for KPV the way there is for the growth hormone secretagogues, so the usual argument for cycling doesn't really apply. What's left is the general principle of not taking something indefinitely when nobody has studied what indefinitely does.

Signs a course is commonly stopped or reconsidered:

• Digestive upset that appears or worsens after starting, which is worth noticing on a compound taken for the gut
• Injection site reactions that don't settle
• Headache or fatigue in the first week
• Eight weeks with no change, which is the point most descriptions of this compound suggest reassessing

Stacking

Most commonly paired stack: KPV with BPC-157.

Rationale: both are reached for on gut problems and they work differently. BPC-157 is described in terms of repairing the gut lining and its blood supply; KPV is described in terms of calming the inflammation happening in it. Repair and quiet, rather than two goes at the same thing.

Protocol as run: both once daily, commonly at the same time, as separate injections or one after the other. Where the target is specifically the intestine, people often run both orally on the same logic, though the oral argument is much stronger for KPV than for BPC-157.

The KLOW blend puts KPV together with GHK-Cu, BPC-157 and TB-500 in one vial, and is the most common way people take this compound without realising it. The ratio is fixed by the vendor, so as with any premixed blend you take whatever proportion they chose.

Lighter stacks: GHK-Cu appears on the skin side, where the two cover different halves of the problem, KPV calming inflammation and GHK-Cu working on the structure. Glutathione comes up as a general anti-inflammatory pairing with no specific rationale connecting the two.

Combinations to approach carefully: nothing specific is flagged, which as usual reflects an absence of study rather than a clean record. Anyone on immune-suppressing medication is combining two things that quiet inflammation, which nobody has looked at.

Expected results timeline

First week or two: where the target is gut inflammation, changes in digestion are what people describe first, and they describe them within a couple of weeks. It's one of the faster-reporting compounds in this category.

Weeks in: skin changes are described over four to eight weeks, slower than the gut effects and more variable.

Extended, continued use: no data. The animal studies ran weeks.

What to expect realistically: the animal evidence here is better than average for this site, in an important way: several independent groups, using different models of gut inflammation, found the same pattern, and identified a coherent mechanism that explains it. That's a real, repeated finding rather than one hopeful result. It is also entirely in mice and cells. Nobody has run this in a person, so what you're relying on is a well-supported mechanism and no human outcome at all.

Administration technique

1. The lyophilized powder is reconstituted with bacteriostatic water, at a concentration set by the reconstitution calculator for the target amount.
2. The solution is swirled gently to dissolve rather than shaken, since agitation can degrade the peptide.
3. The calculated volume is drawn into an insulin syringe, which at 5 to 10 units is the only thing that measures this accurately.
4. A subcutaneous site is chosen, commonly the abdomen, with sites rotated day to day.
5. The skin is pinched and the injection given at roughly a 45-degree angle.
6. Where the oral route is used for gut work instead, it's commonly taken on an empty stomach on the reasoning that less competes with it for the transporter, though that specific detail is convention rather than something established.
7. Timing is otherwise unconstrained: there's no meal or sleep dependency the way there is with the growth hormone compounds.

Side effects and safety

Common: very little is reported. Mild injection site reactions and occasional headache are what come up. This compound's tolerability is consistently described as good, which is consistent with it being a three-amino-acid fragment of something the body already makes.

Less common: digestive upset, which is worth flagging precisely because it's the opposite of the intended effect for most people taking it.

What we don't know: everything about people. There is no human study on KPV at any amount by any route, so tolerability reports are community experience rather than surveillance. Long-run use hasn't been examined even in animals beyond a few weeks.

Contraindications: pregnancy, breastfeeding and use in minors have no data behind them. Anyone taking immune-suppressing medication is stacking two things that quiet inflammation, which is worth thinking about even though nobody has studied it.

Drug interactions: none established. The one worth being aware of in principle is that the transporter carrying KPV into gut cells also carries certain medications, so competition is at least conceivable, though nobody has looked at whether it matters.

KPV vs. BPC-157

BPC-157 is the compound KPV gets cross-shopped against, since both are reached for on gut complaints and both have an oral version in circulation. The difference in what they're actually doing is the useful part.

Choose KPV if: inflammation is the problem rather than damage, the target is the gut or reactive skin, and the oral route appeals.

Choose BPC-157 if: the target is a specific injury or a tissue that needs to rebuild, or you want the compound with at least one human study behind it.

Running both is the common approach for gut work. See the BPC-157 guide and protocols for its own dosing.

Storage and handling

Lyophilized powder: refrigerate at 2 to 8°C and protect from light. Kept frozen, the unreconstituted powder is commonly described as stable considerably longer. Take lot-specific stability from the vendor's certificate of analysis.

Reconstituted solution: refrigerate and use within about 28 days. Some vendors quote a shorter window for this compound specifically, and where they do, use theirs.

Signs of degradation:

• Cloudiness or visible particles in a solution that was previously clear
• Discoloration of the powder or the reconstituted liquid
• Powder that has clumped or gone sticky, which usually means moisture reached it

FAQ

Can I really take this by mouth? For gut work, the rationale is real: it's short enough to survive digestion reasonably well and the gut actively transports it inward. Animal work found oral dosing reduced colitis. For anything outside the gut, that argument doesn't hold.

How much do people run? 250 to 500 mcg daily injected, or 500 mcg to 1 mg orally for gut work. Neither figure comes from a study.

Will it tan my skin like melanotan? No. The pigmentation part of the parent hormone is exactly what was cut away.

Is it in KLOW? Yes, alongside GHK-Cu, BPC-157 and TB-500. Many people take KPV for the first time without realising, as part of that blend.

KPV or BPC-157 for my gut? KPV if inflammation is the problem, BPC-157 if damage is. Many people run both.

Has it been tested in people? No. Not at any amount, by any route.

Can I use it on my skin? People do, mixed into a cream or applied from solution. No concentration is established and how much crosses intact skin is unmeasured.

Which vial should I buy? At 500 mcg daily a 10 mg vial fits inside the 28-day reconstituted window. At 250 mcg daily it doesn't, and a 5 mg vial is the better buy.

Bottom line

Key dosing takeaways:

• 250 to 500 mcg daily injected is the circulating convention, with nothing published behind the figure
• The oral route has a genuine mechanism behind it for gut work specifically, which is rare on this site and is the most useful thing to know about this compound
• The animal evidence is better than average, repeated across independent groups with a coherent mechanism, and there is no human data at all

Best practices:

• Matching the route to the target: oral for gut, injected for anything else, since the transporter argument is a gut argument
• Buying a 5 mg vial at the lower amount, since a 10 mg vial outlasts its own 28-day window at 250 mcg daily
• Checking whether you're already taking it in KLOW before adding it separately

Works best for people who:

• Have an inflammation problem rather than an injury, particularly in the gut
• Want a compound with a coherent, repeated mechanism and can hold that it has never been tested in a person
• Would rather swallow something than inject it, and are using it for the one purpose where that's defensible

KPV is sold for research, and no human study on it exists at any amount by any route. You already know that. You're an adult making an informed call about your own body, and that's yours to make.